Trial Profile
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Aug 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- 28 Feb 2017 New trial record